Characteristics of patients with tumor size ≥2 cm
| Characteristics | All patients (n=673) | P value | After matching (n=436) | P value | ||
| ARH (n=422, %) LRH (n=251, %) | ARH (n=218, %) LRH (n=218, %) | |||||
| Median age, years (range) | 46 (27–75) | 46 (21–72) | 0.17 | 45 (27–71) | 46 (27–72) | 0.68 |
| Tumor size | ||||||
| <2 cm | 422 | 251 | 218 | 218 | ||
| ≥2 cm | 0 | 0 | 0 | 0 | ||
| FIGO stage | ||||||
| IA2 | 3 (0.7) | 8 (3.2) | <0.01 | 1 (0.5) | 1 (0.5) | |
| IB1 | 204 (48.3) | 170 (67.7) | 146 (67.0) | 146 (67.0) | ||
| IIA1 | 215 (51.0) | 73 (29.1) | 71 (32.5) | 71 (32.5) | ||
| Histology | ||||||
| Squamous | 367 (87.0) | 221 (88.0) | 0.82 | 197 (90.4) | 198 (90.8) | 0.99 |
| Adenocarcinoma | 34 (8.1) | 21 (8.4) | 18 (8.2) | 17 (7.8) | ||
| Adenosquamous | 12 (2.8) | 6 (2.4) | 3 (1.4) | 3 (1.4) | ||
| Others | 9 (2.1) | 3 (1.2) | 0 | 0 | ||
| Stromal invasion depth | ||||||
| <1/2 | 142 (33.6) | 99 (39.4) | 0.13 | 76 (34.9) | 88 (40.4) | 0.28 |
| ≥1/2 | 280 (66.4) | 152 (60.6) | 142 (65.1) | 130 (59.6) | ||
| LVSI | ||||||
| Negative | 262 (62.1) | 153 (61.0) | 0.77 | 144 (66.1) | 136 (62.4) | 0.48 |
| Positive | 160 (37.9) | 98 (39.0) | 74 (33.9) | 82 (37.6) | ||
| Parametrial involvement | ||||||
| Negative | 390 (92.4) | 235 (93.6) | 0.56 | 208 (95.4) | 203 (93.1) | 0.41 |
| Positive | 32 (7.6) | 16 (6.4) | 10 (4.6) | 15 (6.9) | ||
| PLN metastasis | ||||||
| Negative | 328 (77.7) | 195 (77.7) | 0.99 | 170 (78.0) | 171 (78.4) | 0.91 |
| Positive | 94 (22.3) | 56 (22.3) | 48 (22.0) | 47 (21.6) | ||
| PALN metastasis | ||||||
| Negative | 89 (21.1) | 34 (13.5) | 0.87 | 42 (19.3) | 31 (14.2) | 0.91 |
| Positive | 6 (1.4) | 2 (0.8) | 3 (1.4) | 2 (0.9) | ||
| Postoperative radiochemotherapy | ||||||
| Yes | 282 (66.8) | 175 (69.7) | 0.41 | 73 (33.5) | 68 (31.2) | 0.54 |
| No | 140 (33.2) | 76 (30.3) | 145 (66.5) | 150 (68.8) | ||
| Recurrence | ||||||
| Yes | 52 (12.3) | 33 (13.1) | 0.76 | 17 (7.8) | 28 (12.8) | 0.12 |
| No | 370 (87.7) | 218 (86.9) | 201 (92.2) | 190 (87.2) | ||
| Death | ||||||
| Yes | 48 (11.4) | 25 (10.0) | 0.57 | 19 (8.7) | 21 (9.6) | 0.74 |
| No | 374 (88.6) | 226 (90.0) | 199 (91.3) | 197 (90.4) | ||
ARH, abdominal radical hysterctomy; FIGO, International Federation of Gynecology and Obstetrics; LRH, laparoscopic radical hysterectomy; LVSI, lymphovascular space invasion; PALN, para-aortic lymph node; PLN, pelvic lymph node.